What is IVF MORE®?
IVF MORE®: Restore the Quality of Your Eggs
An exclusive technique of Instituto Ingenes, IVF MORE® (Magnetic Ovulatory Restoration) improves the quality of your eggs through advanced ovarian restoration. By creating a unique pathway to pregnancy without the need for an egg donation, IVF MORE® offers new possibilities for women facing fertility challenges, especially those over 40 who wish to become mothers.
- 19+ babies born with this technology
- 3 months of treatment, approximately
- 1 mature egg is enough to try
Who can benefit from IVF MORE®?
An alternative to egg donation
IVF MORE® offers an alternative to egg donation, designed for women facing challenges related to egg quality due to:
- Advanced age
- Endometriosis
- Polycystic Ovary Syndrome (PCOS)
- Repeated failed IVF attempts
- Embryos with chromosomal abnormalities (detected with PGT-A)
Even with a single mature egg, IVF MORE® can be applied.
Who can benefit from IVF MORE®?
IVF MORE® process
How IVF MORE® works
The goal of IVF MORE® is to restore poor-quality eggs and give them a new chance to become viable embryos.
-
Ovarian stimulation
The ovaries are stimulated to obtain eggs, as in a traditional IVF cycle.
-
Metabolic evaluation of the eggs
Each egg is analyzed individually to detect possible energy deficiencies.
-
Personalized cytoplasmic restoration
Energetic and mitochondrial factors are infused into the egg to reinforce weakened cellular functions. Donor cytoplasm may be used in some cases, but the genetic material remains 100% yours.
-
Advanced sperm selection and ICSI
The best sperm are selected using advanced techniques and the restored eggs are fertilized through intracytoplasmic sperm injection.
-
Embryo culture in magnetic fields
Embryos develop in a special environment that promotes optimal, healthy cell division.
-
Embryo transfer
Viable embryos are transferred to the uterus, seeking to maximize the chances of pregnancy.
Frequently asked questions
What patients ask us first
How long does the full treatment take?
The complete treatment takes approximately 3 months.
When is it advisable to accumulate more eggs?
Even with a single mature egg we can apply IVF MORE®. If there are no viable eggs, a second stimulation may be considered.
What are the limitations of the technique?
IVF MORE® requires at least one mature egg. If none is produced, even with stimulation, the technique cannot be applied. In some cases, even when eggs are available, they may not be viable or respond adequately to restoration. When that happens, egg donation may be the most effective alternative.
Are there complementary treatments?
Yes. Ovagen improves ovarian response in women with low ovarian reserve, and Endogen improves endometrial receptivity for women with implantation failure.
Our story
Innovation That Transforms Lives
At IVF MORE® we combine the most advanced science with regenerative medicine to offer new possibilities to those seeking to build a family. Our technique was developed in collaboration with Dr. Shoukhrat Mitalipov, biologist and university professor in Oregon, using the latest in molecular biology to restore poor-quality eggs.
- 19+ Babies born with this technology
- 3 Months, approximate treatment time
- 6 Steps in the protocol
- 1 Mature egg is enough to try
Age in fertility
Overcoming fertility barriers beyond age
Although traditional IVF success rates decline after 35, IVF MORE® offers an innovative technique. It improves the chances of conceiving with your own eggs without resorting to egg donation. Instead of depending on eggs from younger donors, IVF MORE® helps overcome the challenges of age, endometriosis and PCOS, providing new hope for achieving a successful pregnancy.
Scientific sources5
- (2022). Live births per intended egg retrieval, national summary report. SART CORS.
- (2023). 1 in 6 people globally affected by infertility. WHO.
- (2023). Potential factors result in diminished ovarian reserve: a comprehensive review. Journal of Ovarian Research.
- (2016). How a High-Gradient Magnetic Field Could Affect Cell Life. Scientific Reports (Nature).
- . Meet Shoukhrat Mitalipov, Ph.D., Center for Embryonic Cell and Gene Therapy. OHSU.